Leong; Kahan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leong; Kahan.The latest application filed is for "novel serpentine transmembrane antigens expressed in human cancers and uses thereof".

Company Profile

1.23.21

Leong; Kahan - Playa Del Rey CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 8,414,898 - Afar , et al. April 9, 2	2013-04-09
13-transmembrane protein expressed in prostate cancer Grant 8,383,777 - Afar , et al. February 26, 2	2013-02-26
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20110318371 - Afar; Daniel E. ; et al.	2011-12-29
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells Grant 8,003,758 - Afar , et al. August 23, 2	2011-08-23
Methods to detect tumors using 20P1F12/TMPRSS2 expression Grant 7,981,624 - Afar , et al. July 19, 2	2011-07-19
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,968,307 - Afar , et al. June 28, 2	2011-06-28
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,928,201 - Afar , et al. April 19, 2	2011-04-19
Antibodies to protein expressed in prostate cancer Grant 7,858,760 - Afar , et al. December 28, 2	2010-12-28
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells Grant 7,785,811 - Afar , et al. August 31, 2	2010-08-31
Novel Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof App 20100190962 - Afar; Daniel E. ; et al.	2010-07-29
Novel Serpentine Transmembrane Antigens Expressed In Human Cancers And Uses Thereof App 20100173297 - AFAR; DANIEL E. ; et al.	2010-07-08
Bpc-1: A Secreted Brain-specific Protein Expressed And Secreted By Prostate And Bladder Cancer Cells App 20100168027 - AFAR; Daniel E. ; et al.	2010-07-01
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,642,054 - Afar , et al. January 5, 2	2010-01-05
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,611,904 - Afar , et al. November 3, 2	2009-11-03
Methods To Detect Tumors Using 20p1f12/tmprss2 Expression App 20090226921 - AFAR; Daniel E. H. ; et al.	2009-09-10
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,575,749 - Afar , et al. August 18, 2	2009-08-18
Novel 13-transmembrane Protein Expressed In Prostate Cancer App 20080178308 - Afar; Daniel E. ; et al.	2008-07-24
13-transmembrane protein expressed in prostate cancer Grant 7,306,796 - Afar , et al. December 11, 2	2007-12-11
13-transmembrane protein expressed in prostate cancer Grant 7,227,008 - Afar , et al. June 5, 2	2007-06-05
Transmembrane protein expressed in prostate and other cancers Grant 7,220,823 - Afar , et al. May 22, 2	2007-05-22
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20070104720 - Afar; Daniel E. ; et al.	2007-05-10
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 7,166,714 - Afar , et al. January 23, 2	2007-01-23
Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer App 20060275304 - Afar; Daniel E. ; et al.	2006-12-07
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20060147951 - Afar; Daniel E. ; et al.	2006-07-06
Antibodies immunospecific for STEAP1 Grant 7,053,186 - Afar , et al. May 30, 2	2006-05-30
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer Grant 7,037,667 - Afar , et al. May 2, 2	2006-05-02
Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer App 20050239122 - Afar, Daniel E.H. ; et al.	2005-10-27
Novel serpentine transmembrane antigens expressed in human cancers and uses thereof App 20050202454 - Afar, Daniel E. ; et al.	2005-09-15
Transmembrane protein expressed in prostate cancer Grant 6,943,235 - Afar , et al. September 13, 2	2005-09-13
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells App 20050148012 - Afar, Daniel E. ; et al.	2005-07-07
Peptides derived from STEAP1 Grant 6,887,975 - Afar , et al. May 3, 2	2005-05-03
Serpentine transmembrane antigens expressed in human cancers and uses thereof App 20050064445 - Afar, Daniel E. ; et al.	2005-03-24
Protein expressed in prostate cancer App 20050019870 - Afar, Daniel E. ; et al.	2005-01-27
Novel prostate-restricted gene expressed in prostate cancer App 20040265310 - Afar, Daniel E. ; et al.	2004-12-30
Novel 13-transmembrane protein expressed in prostate cancer App 20040253618 - Afar, Daniel E. ; et al.	2004-12-16
Novel 13-transmembrane protein expressed in prostate cancer App 20030157521 - Afar, Daniel E. ; et al.	2003-08-21
Novel 13-transmembrane protein expressed in prostate cancer App 20030147904 - Afar, Daniel E. ; et al.	2003-08-07
Peptides derived from STEAP1 App 20030055217 - Afar, Daniel E. ; et al.	2003-03-20
Antibodies immunospecific for STEAP1 App 20030045682 - Afar, Daniel E. ; et al.	2003-03-06
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells App 20020161212 - Afar, Daniel E. ; et al.	2002-10-31
Serpentine transmembrane antigens expressed in human cancers and uses thereof Grant 6,329,503 - Afar , et al. December 11, 2	2001-12-11
BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells Grant 6,277,972 - Afar , et al. August 21, 2	2001-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.